Physician profile
David Battin
NPI 1700881000
$29,563.02
in general payments reported to CMS, 2019-2025
44 companies · $4,272 in 2025
The $4,272 reported for 2025 was more than what 81% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,049 · 2020: $1,834 · 2021: $3,353 · 2022: $6,704 · 2023: $5,687 · 2024: $4,665 · 2025: $4,272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Travel and Lodging: $2,701 · Education: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,673.65 |
| Travel and Lodging | $2,700.72 |
| Education | $249.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $11,855.50 | 2021-2025 | Corevalve Evolut R, Linq II, Na |
| Boston Scientific Corporation | $2,799.31 | 2019-2025 | Watchman Access System, Watchman Flx, Watchman |
| Endologix LLC | $2,727.97 | 2022-2024 | Alto Abdominal Stent Graft System |
| Medtronic Vascular, INC. | $2,394.25 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $1,073.65 | 2019-2025 | |
| Abbott Laboratories | $1,056.08 | 2021-2025 | Cardiomems, Esprit, Jeti Peripheral Catheter |
| Astrazeneca Pharmaceuticals LP | $885.63 | 2019-2024 | Farxiga |
| Abiomed | $862.74 | 2021-2025 | Impella |
| Pfizer INC. | $815.35 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $655.88 | 2021-2025 | Verquvo |
| Janssen Pharmaceuticals, INC | $643.58 | 2019-2022 | |
| Inari Medical, INC. | $531.93 | 2020-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| E.R. Squibb & Sons, L.L.C. | $515.13 | 2020-2024 | Camzyos, Eliquis |
| Amgen INC. | $476.40 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $372.35 | 2019-2025 | Lifevest |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $270.18 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $251.95 | 2021-2025 | Jardiance |
| Philips North America LLC | $144.20 | 2022-2025 | (Br6) Re Entry, Extended Holter, (Ao0) Igt Devices Intracardiac |
| Sanofi-Aventis U.S. LLC | $133.05 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $114.24 | 2019 | |
| Shockwave Medical, INC | $113.26 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Edwards Lifesciences Corporation | $96.19 | 2020 | |
| Stryker Corporation | $90.10 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Cvrx, INC. | $75.15 | 2021-2022 | |
| Kestra Medical Technology Services, INC. | $73.54 | 2025 | Assure Wcd |
| Cardiva Medical, INC. | $69.51 | 2022-2023 | Cardiva Vascade 6/7f Vcs |
| Bardy Diagnostics, INC. | $57.00 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $46.73 | 2025 | |
| Astellas Pharma US INC | $42.73 | 2019 | |
| Terumo Medical Corporation | $41.31 | 2022-2024 | Azur Cx Detachable |
| Akcea Therapeutics, INC. | $38.45 | 2020-2021 | |
| Actelion Pharmaceuticals US, INC. | $36.11 | 2019-2021 | |
| Gilead Sciences, INC. | $29.72 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $22.13 | 2024 | |
| W. L. Gore & Associates, INC. | $18.18 | 2024 | Gore Excluder Iliac Branch Endoprosthesis |
| Alnylam Pharmaceuticals INC. | $17.41 | 2020 | |
| Infobionic, INC | $16.95 | 2020 | |
| Chiesi USA, INC. | $16.28 | 2021 | |
| Scpharmaceuticals INC. | $15.58 | 2025 | |
| Teleflex LLC | $14.70 | 2021 | |
| Amryt Pharma Holdings LTD | $14.56 | 2020 | |
| Novo Nordisk INC | $14.47 | 2023 | Ozempic, Rybelsus |
| Ekos Corporation | $13.59 | 2019 | |
| Penumbra, INC. | $10.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Battin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.